Zydus gets EIR for injectables manufacturing facility at Zydus Biotech Park
The inspection had concluded with NIL observations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Zydus gets US FDA approval for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
Isotretinoin Capsules is used to treat severe cystic acne (also known as nodular acne) that has not responded to other treatment
Zydus gets USFDA approval for Indomethacin suppository with CGT designation
The company has been granted 180-day CGT exclusivity to market this product
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients…
Phase IV EVIDENCES- XI trial will enroll approximately 1500 NAFLD patients with comorbidities
Eminence Business Media hosts sixth edition of Annual Pharma Project & Portfolio Management…
The programme comprised various discussion topics for project and portfolio management teams through interactive sessions and…
Zydus gets USFDA approval for Icosapent Ethyl Capsules, 0.5 g and 1 g
Icosapent Ethyl Capsules, 0.5 g and 1 g had annual sales of $1,316 million in the US
Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Zydus gets USFDA approval for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25…
Carbidopa and Levodopa are used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Zydus gets USFDA nod for Acetazolamide Tablets USP, 125 mg and 250 mg
Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision.…
Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic…
Orphan drug designation by USFDA for ZYIL1 provides eligibility for certain development incentives, including tax credits for…